Onconova Therapeutics Announces Completion of Enrollment of Phase 3 INSPIRE Trial, Provides ...
LATEST
- Medicine Branch (A-M) / Hematology
Onconova Therapeutics Announces Completion of Enrollment of Phase 3 INSPIRE Trial, Provides ...
NEWTOWN, Pa., March 24, 2020 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX), a Phase 3 stage biopharmaceutical company focused on discovering and developing novel products to treat cancer, with an initial focus on myelodysplastic s.